CVS Health Corporation CVS
89.13
4.08
4.80%
as of 25 Sep
- Market cap
- $108.5B
- P/E
- 23.3×
Follow CVS
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
CVS Health Corporation (CVS) P/S ratio
As of 25 September 2026, CVS Health Corporation (CVS) trades at a P/S ratio of 0.3×. Over the past ten years it has ranged from 0.1× (January 2025) to 0.9× (July 2015); the current reading is higher than 24% of that period. That is below the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.3× | 64.97% |
| FY2024 | 0.2× | (47.80%) |
| FY2023 | 0.3× | (23.17%) |
| FY2022 | 0.4× | (18.85%) |
| FY2021 | 0.5× | 40.01% |
| FY2020 | 0.3× | (11.61%) |
| FY2019 | 0.4× | 7.08% |
| FY2018 | 0.4× | (13.38%) |
| FY2017 | 0.4× | (16.43%) |
| FY2016 | 0.5× | (31.90%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.3× | 42.26% |
| Mar 2026 | 0.2× | (10.40%) |
| Dec 2025 | 0.3× | 3.01% |
| Sep 2025 | 0.2× | 7.48% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.1×
High 0.9×
Ten-year median
0.4×
Current reading's percentile
24
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| CNC Centene Corporation compare | 0.2× |
| MOH Molina Healthcare, Inc compare | 0.2× |
| CI Cigna Group compare | 0.3× |
| CVS CVS Health Corporation | 0.3× |
| HUM Humana Inc. compare | 0.3× |
| ELV Elevance Health, Inc. compare | 0.4× |
| OSCR Oscar Health, Inc. compare | 0.6× |
| UNH UnitedHealth Group Incorporated compare | 0.8× |
| CLOV Clover Health Investments, Corp. compare | 1.0× |
| Healthcare Plans industry median | 0.4× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CVS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement